FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 329:921-925 September 23, 1993 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Bies, R. D. PubMed Citation

Several forms of hereditary dilated cardiomyopathy have been identified; with the exception of those resulting from mutations of mitochondrial DNA,^1,2 no pathological finding can be used to differentiate the conditions, so their distinction depends on the pattern of transmission. Autosomal recessive, autosomal dominant, and matrilinear forms have been reported; several families with X-linked dilated cardiomyopathy have also been described^3,4,5.

X-linked dilated cardiomyopathy is a progressive myocardial disease presenting as congestive heart failure in teenage boys without clinical signs of skeletal myopathy⁵. No information is available on the pathogenetic defect involved in this disorder, although cardiomyopathy is an associated . . . [Full Text of this Article]

Case Report

Methods

Immunohistochemical Study of Skeletal Muscle

DNA Studies

Results

Muscle Biopsy

DNA Analysis

Discussion

Source Information

From the Istituto di Neuropsichiatria Infantile (F.M., A.M., M.G.M., C.C.) and the Istituto di Clinica e Biologia dell'Eta' Evolutiva (M.C., R.C., A.C., M.A.M.), Cagliari; and the Istituto di Clinica Medica Generale e Terapia Medica, Sassari (A.G., G.A., G.R.) -- all in Italy.

Address reprint requests to Dr. Muntoni at the Department of Paediatrics and Neonatal Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, Du Cane Rd., London W12 OHS, United Kingdom.

References

Related Letters:

X-Linked Dilated Cardiomyopathy
Bies R. D., Roubicek M., Towbin J. A., Ortiz-Lopez R., Muntoni F.
Extract | Full Text  
N Engl J Med 1994; 330:368-370, Feb 3, 1994. Correspondence

This article has been cited by other articles:

• Philipp, U., Broschk, C., Vollmar, A., Distl, O. (2007). Evaluation of Tafazzin as Candidate for Dilated Cardiomyopathy in Irish Wolfhounds. J Hered 0: esm045v1- [Abstract] [Full Text]  
• Kimura, S., Ikezawa, M., Ozasa, S., Ito, K., Ueno, H., Yoshioka, K., Ijiri, S., Nomura, K., Nakamura, K., Matuskura, M., Miike, T. (2007). Novel Mutation in Splicing Donor of Dystrophin Gene First Exon in a Patient With Dilated Cardiomyopathy but No Clinical Signs of Skeletal Myopathy. J Child Neurol 22: 901-906 [Abstract]  
• Ashrafian, H., Watkins, H. (2007). Reviews of Translational Medicine and Genomics in Cardiovascular Disease: New Disease Taxonomy and Therapeutic Implications: Cardiomyopathies: Therapeutics Based on Molecular Phenotype. J Am Coll Cardiol 49: 1251-1264 [Abstract] [Full Text]  
• Section on Cardiology and Cardiac Surgery, (2005). Cardiovascular Health Supervision for Individuals Affected by Duchenne or Becker Muscular Dystrophy. Pediatrics 116: 1569-1573 [Abstract] [Full Text]  
• Bridges, C. R., Gopal, K., Holt, D. E., Yarnall, C., Cole, S., Anderson, R. B., Yin, X., Nelson, A., Kozyak, B. W., Wang, Z., Lesniewski, J., Su, L. T., Thesier, D. M., Sundar, H., Stedman, H. H. (2005). Efficient myocyte gene delivery with complete cardiac surgical isolation in situ. J. Thorac. Cardiovasc. Surg. 130: 1364-1364 [Abstract] [Full Text]  
• Mahon, N. G., Murphy, R. T., MacRae, C. A., Caforio, A. L.P., Elliott, P. M., McKenna, W. J. (2005). Echocardiographic Evaluation in Asymptomatic Relatives of Patients with Dilated Cardiomyopathy Reveals Preclinical Disease. ANN INTERN MED 143: 108-115 [Abstract] [Full Text]  
• Burkett, E. L., Hershberger, R. E. (2005). Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol 45: 969-981 [Abstract] [Full Text]  
• Hayashi, T., Arimura, T., Itoh-Satoh, M., Ueda, K., Hohda, S., Inagaki, N., Takahashi, M., Hori, H., Yasunami, M., Nishi, H., Koga, Y., Nakamura, H., Matsuzaki, M., Choi, B. Y., Bae, S. W., You, C. W., Han, K. H., Park, J. E., Knoll, R., Hoshijima, M., Chien, K. R., Kimura, A. (2004). Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J Am Coll Cardiol 44: 2192-2201 [Abstract] [Full Text]  
• De Repentigny, Y., Marshall, P., Worton, R. G., Kothary, R. (2004). The mouse dystrophin muscle enhancer-1 imparts skeletal muscle, but not cardiac muscle, expression onto the dystrophin Purkinje promoter in transgenic mice. Hum Mol Genet 13: 2853-2862 [Abstract] [Full Text]  
• Katsuragi, N., Morishita, R., Nakamura, N., Ochiai, T., Taniyama, Y., Hasegawa, Y., Kawashima, K., Kaneda, Y., Ogihara, T., Sugimura, K. (2004). Periostin as a Novel Factor Responsible for Ventricular Dilation. Circulation 110: 1806-1813 [Abstract] [Full Text]  
• Cohen, N, Muntoni, F (2004). Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy. Heart 90: 835-841 [Abstract] [Full Text]  
• Karkkainen, S., Helio, T., Miettinen, R., Tuomainen, P., Peltola, P., Rummukainen, J., Ylitalo, K., Kaartinen, M., Kuusisto, J., Toivonen, L., Nieminen, M. S, Laakso, M., Peuhkurinen, K. (2004). A novel mutation, Ser143Pro, in the lamin A/C gene is common in finnish patients with familial dilated cardiomyopathy. Eur Heart J 25: 885-893 [Abstract] [Full Text]  
• Lapidos, K. A., Kakkar, R., McNally, E. M. (2004). The Dystrophin Glycoprotein Complex: Signaling Strength and Integrity for the Sarcolemma. Circ. Res. 94: 1023-1031 [Abstract] [Full Text]  
• Pyle, W. G., Solaro, R. J. (2004). At the Crossroads of Myocardial Signaling: The Role of Z-Discs in Intracellular Signaling and Cardiac Function. Circ. Res. 94: 296-305 [Abstract] [Full Text]  
• Towbin, J. A. (2003). A noninvasive means of detecting preclinical cardiomyopathy in Duchenne muscular dystrophy?. J Am Coll Cardiol 42: 317-318 [Full Text]  
• Scopacasa, B. S., Teixeira, V. P. A., Franchini, K. G. (2003). Colchicine attenuates left ventricular hypertrophy but preserves cardiac function of aortic-constricted rats. J. Appl. Physiol. 94: 1627-1633 [Abstract] [Full Text]  
• Taylor, M. R. G., Fain, P. R., Sinagra, G., Robinson, M. L., Robertson, A. D., Carniel, E., Di Lenarda, A., Bohlmeyer, T. J., Ferguson, D. A., Brodsky, G. L., Boucek, M. M., Lascor, J., Moss, A. C., Li, W.-L. P., Stetler, G. L., Muntoni, F., Bristow, M. R., Mestroni, L., Familial Dilated Cardiomyopathy Registry Research, (2003). Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol 41: 771-780 [Abstract] [Full Text]  
• Doevendans, P. A. (2003). Genetic Polymorphisms and Cardiac Failure. SEMIN CARDIOTHORAC VASC ANESTH 7: 23-29  
• Muntoni, F. (2003). Cardiac Complications of Childhood Myopathies. J Child Neurol 18: 191-202 [Abstract]  
• Bowles, N.E. (2002). The molecular biology of dilated cardiomyopathy. Eur Heart J Suppl 4: I2-I7 [Abstract]  
• Feng, J., Yan, J., Buzin, C. H., Sommer, S. S., Towbin, J. A. (2002). Comprehensive mutation scanning of the dystrophin gene in patients with nonsyndromic X-linked dilated cardiomyopathy. J Am Coll Cardiol 40: 1120-1124 [Abstract] [Full Text]  
• Mahon, N. G., Madden, B. P., Caforio, A. L. P., Elliott, P. M., Haven, A. J., Keogh, B. E., Davies, M. J., McKenna, W. J. (2002). Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy. J Am Coll Cardiol 39: 455-462 [Abstract] [Full Text]  
• Olson, T. M., Illenberger, S., Kishimoto, N. Y., Huttelmaier, S., Keating, M. T., Jockusch, B. M. (2002). Metavinculin Mutations Alter Actin Interaction in Dilated Cardiomyopathy. Circulation 105: 431-437 [Abstract] [Full Text]  
• Miyamoto, Y., Akita, H., Shiga, N., Takai, E., Iwai, C., Mizutani, K., Kawai, H., Takarada, A., Yokoyama, M. (2001). Frequency and clinical characteristics of dilated cardiomyopathy caused by desmin gene mutation in a Japanese population. Eur Heart J 22: 2284-2289 [Abstract]  
• Bastianutto, C., Bestard, J. A., Lahnakoski, K., Broere, D., De Visser, M., Zaccolo, M., Pozzan, T., Ferlini, A., Muntoni, F., Patarnello, T., Klamut, H. J. (2001). Dystrophin muscle enhancer 1 is implicated in the activation of non-muscle isoforms in the skeletal muscle of patients with X-linked dilated cardiomyopathy. Hum Mol Genet 10: 2627-2635 [Abstract] [Full Text]  
• Su, Z., Yao, A., Zubair, I., Sugishita, K., Ritter, M., Li, F., Hunter, J. J., Chien, K. R., Barry, W. H. (2001). Effects of deletion of muscle LIM protein on myocyte function. Am. J. Physiol. Heart Circ. Physiol. 280: H2665-H2673 [Abstract] [Full Text]  
• Saotome, M., Yoshitomi, Y., Kojima, S., Kuramochi, M. (2001). Dilated Cardiomyopathy of Becker-Type Muscular Dystrophy with Exon 4 Deletion: A Case Report. ANGIOLOGY 52: 343-347 [Abstract]  
• Ichida, F., Tsubata, S., Bowles, K. R., Haneda, N., Uese, K., Miyawaki, T., Dreyer, W. J., Messina, J., Li, H., Bowles, N. E., Towbin, J. A. (2001). Novel Gene Mutations in Patients With Left Ventricular Noncompaction or Barth Syndrome. Circulation 103: 1256-1263 [Abstract] [Full Text]  
• Arbustini, E., Morbini, P., Pilotto, A., Gavazzi, A., Tavazzi, L. (2000). Familial dilated cardiomyopathy: from clinical presentation to molecular genetics. Eur Heart J 21: 1825-1832  
• KOMAJDA, M (2000). Genetics of dilated cardiomyopathy: a molecular maze?. Heart 84: 463-464 [Full Text]  
• Badorff, C., Fichtlscherer, B., Rhoads, R. E., Zeiher, A. M., Muelsch, A., Dimmeler, S., Knowlton, K. U. (2000). Nitric Oxide Inhibits Dystrophin Proteolysis by Coxsackieviral Protease 2A Through S-Nitrosylation : A Protective Mechanism Against Enteroviral Cardiomyopathy. Circulation 102: 2276-2281 [Abstract] [Full Text]  
• Lee, G.-H., Badorff, C., Knowlton, K. U. (2000). Dissociation of Sarcoglycans and the Dystrophin Carboxyl Terminus From the Sarcolemma in Enteroviral Cardiomyopathy. Circ. Res. 87: 489-495 [Abstract] [Full Text]  
• Arbustini, E., Diegoli, M., Morbini, P., Dal Bello, B., Banchieri, N., Pilotto, A., Magani, F., Grasso, M., Narula, J., Gavazzi, A., Vigano, M., Tavazzi, L. (2000). Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy. J Am Coll Cardiol 35: 1760-1768 [Abstract] [Full Text]  
• Badorff, C., Berkely, N., Mehrotra, S., Talhouk, J. W., Rhoads, R. E., Knowlton, K. U. (2000). Enteroviral Protease 2A Directly Cleaves Dystrophin and Is Inhibited by a Dystrophin-based Substrate Analogue. J. Biol. Chem. 275: 11191-11197 [Abstract] [Full Text]  
• Brodsky, G. L., Muntoni, F., Miocic, S., Sinagra, G., Sewry, C., Mestroni, L. (2000). Lamin A/C Gene Mutation Associated With Dilated Cardiomyopathy With Variable Skeletal Muscle Involvement. Circulation 101: 473-476 [Abstract] [Full Text]  
• Haefliger, J.-A., Goy, J.J., Waeber, G. (1999). Sporadic cases of dilated cardiomyopathies associated with atrioventricular conduction defects are not linked to mutation within the connexins 40 and 43 genes. Eur Heart J 20: 1843-1843  
• Fatkin, D., MacRae, C., Sasaki, T., Wolff, M. R., Porcu, M., Frenneaux, M., Atherton, J., Vidaillet, H. J., Spudich, S., De Girolami, U., Seidman, J.G., Seidman, C. E., Muntoni, F., Muehle, G., Johnson, W., McDonough, B. (1999). Missense Mutations in the Rod Domain of the Lamin A/C Gene as Causes of Dilated Cardiomyopathy and Conduction-System Disease. NEJM 341: 1715-1724 [Abstract] [Full Text]  
• Mestroni, L., Rocco, C., Gregori, D., Sinagra, G., Di Lenarda, A., Miocic, S., Vatta, M., Pinamonti, B., Muntoni, F., Caforio, A. L. P., McKenna, W. J., Falaschi, A., Giacca, M., Camerini, F., the Heart Muscle Disease Study Group, (1999). Familial dilated cardiomyopathy: Evidence for genetic and phenotypic heterogeneity. J Am Coll Cardiol 34: 181-190 [Abstract] [Full Text]  
• Yang, D., Yu, J., Luo, Z., Carthy, C. M., Wilson, J. E., Liu, Z., McManus, B. M. (1999). Viral Myocarditis : Identification of Five Differentially Expressed Genes in Coxsackievirus B3–Infected Mouse Heart. Circ. Res. 84: 704-712 [Abstract] [Full Text]  
• Priori, S. G., Barhanin, J., Hauer, R. N. W., Haverkamp, W., Jongsma, H. J., Kleber, A. G., McKenna, W. J., Roden, D. M., Rudy, Y., Schwartz, K., Schwartz, P. J., Towbin, J. A., Wilde, A. M. (1999). Genetic and Molecular Basis of Cardiac Arrhythmias: Impact on Clinical Management Parts I and II. Circulation 99: 518-528 [Abstract] [Full Text]  
• Priori, S.G., Barhanin, J., Hauer, R.N.W., Haverkamp, W., Jongsma, H.J., Kleber, A.G., McKenna, W.J., Roden, D.M., Rudy, Y., Schwartz, K., Schwartz, P.J., Towbin, J.A., Wilde, A. (1999). Genetic and molecular basis of cardiac arrhythmias: Impact on clinical management. Eur Heart J 20: 174-195  
• Banwell, B. L., Becker, L. E., Jay, V., Taylor, G. P., Vajsar, J. (1999). Cardiac Manifestations of Congenital Fiber-Type Disproportion Myopathy. J Child Neurol 14: 83-87 [Abstract]  
• Ichihara, S., Yamada, Y., Yokota, M. (1998). Association of a G994->T Missense Mutation in the Plasma Platelet-Activating Factor Acetylhydrolase Gene With Genetic Susceptibility to Nonfamilial Dilated Cardiomyopathy in Japanese. Circulation 98: 1881-1885 [Abstract] [Full Text]  
• Jones, H. R., de la Monte, S. M. (1998). Case 22-1998- A 22-Year-Old Man with a Cardiac Transplant and Creatine Kinase Elevation. NEJM 339: 182-190 [Full Text]  
• Gallagher, P. G., Forget, B. G. (1998). An Alternate Promoter Directs Expression of a Truncated, Muscle-specific Isoform of the Human Ankyrin 1 Gene. J. Biol. Chem. 273: 1339-1348 [Abstract] [Full Text]  
• Sakamoto, A., Ono, K., Abe, M., Jasmin, G., Eki, T., Murakami, Y., Masaki, T., Toyo-oka, T., Hanaoka, F. (1997). Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta -sarcoglycan, in hamster: An animal model of disrupted dystrophin-associated glycoprotein complex. Proc. Natl. Acad. Sci. USA 94: 13873-13878 [Abstract] [Full Text]  
• Muntoni, F., Di Lenarda, A., Porcu, M., Sinagra, G., Mateddu, A., Marrosu, G., Ferlini, A., Cau, M., Milasin, J., Melis, M. A., Marrosu, M. G., Cianchetti, C., Sanna, A., Falaschi, A., Camerini, F., Giacca, M., Mestroni, L. (1997). Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy. Heart 78: 608-612 [Abstract] [Full Text]  
• Leiden, J. M. (1997). The Genetics of Dilated Cardiomyopathy -- Emerging Clues to the Puzzle. NEJM 337: 1080-1081 [Full Text]  
• Bowles, N. E., Wang, Q., Towbin, J. A. (1997). Prospects for adenovirus-mediated gene therapy of inherited diseases of the myocardium. Cardiovasc Res 35: 422-430 [Full Text]  
• Beggs, A. H. (1997). Dystrophinopathy, The Expanding Phenotype: Dystrophin Abnormalities in X-Linked Dilated Cardiomyopathy. Circulation 95: 2344-2347 [Full Text]  
• Ortiz-Lopez, R., Li, H., Su, J., Goytia, V., Towbin, J. A. (1997). Evidence for a Dystrophin Missense Mutation as a Cause of X-Linked Dilated Cardiomyopathy. Circulation 95: 2434-2440 [Abstract] [Full Text]  
• Maeda, M., Holder, E., Lowes, B., Valent, S., Bies, R. D. (1997). Dilated Cardiomyopathy Associated With Deficiency of the Cytoskeletal Protein Metavinculin. Circulation 95: 17-20 [Abstract] [Full Text]  
• Melacini, P., Fanin, M., Danieli, G.A., Villanova, C., Martinello, F., Miorin, M., Freda, M.P., Miorelli, M., Mostacciuolo, M.L., Fasoli, G., Angelini, C., Volta, S. D. (1996). Myocardial Involvement Is Very Frequent Among Patients Affected With Subclinical Becker's Muscular Dystrophy. Circulation 94: 3168-3175 [Abstract] [Full Text]  
• Schwartz, M. L., Cox, G. F., Lin, A. E., Korson, M. S., Perez-Atayde, A., Lacro, R. V., Lipshultz, S. E. (1996). Clinical Approach to Genetic Cardiomyopathy in Children. Circulation 94: 2021-2038 [Abstract] [Full Text]  
• Meng, H., Leddy, J. J., Frank, J., Holland, P., Tuana, B. S. (1996). The Association of Cardiac Dystrophin with Myofibrils/Z-disc Regions in Cardiac Muscle Suggests a Novel Role in the Contractile Apparatus. J. Biol. Chem. 271: 12364-12371 [Abstract] [Full Text]  
• Fadic, R., Sunada, Y., Waclawik, A. J., Buck, S., Lewandoski, P. J., Campbell, K. P., Lotz, B. P. (1996). Deficiency of a Dystrophin-Associated Glycoprotein (Adhalin) in a Patient with Muscular Dystrophy and Cardiomyopathy. NEJM 334: 362-366 [Full Text]  
• Samaha, F. J., Quinlan, J. G. (1996). Topical Review: Dystrophinopathies: Clarification and Complication. J Child Neurol 11: 13-20 [Abstract]  
• Samaha, F. J., Quinlan, J. G. (1996). Myalgia and Cramps: Dystrophinopathy With Wide-Ranging Laboratory Findings. J Child Neurol 11: 21-24 [Abstract]  
• Kelly, D. P., Strauss, A. W. (1994). Inherited Cardiomyopathies. NEJM 330: 913-919 [Full Text]  
• Bies, R. D., Roubicek, M., Towbin, J. A., Ortiz-Lopez, R., Muntoni, F. (1994). X-Linked Dilated Cardiomyopathy. NEJM 330: 368-370 [Full Text]  
• Michels, V. V. (1993). Progress in Defining the Causes of Idiopathic Dilated Cardiomyopathy. NEJM 329: 960-961 [Full Text]  
• Marshall, P., Chartrand, N., Worton, R. G. (2001). The Mouse Dystrophin Enhancer Is Regulated by MyoD, E-box-binding Factors, and by the Serum Response Factor. J. Biol. Chem. 276: 20719-20726 [Abstract] [Full Text]  
• Frey, N., Richardson, J. A., Olson, E. N. (2000). Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. Proc. Natl. Acad. Sci. USA 97: 14632-14637 [Abstract] [Full Text]